Benzinga | Aug 11, 2021 06:35AM EDT

HC Wainwright & Co. Maintains Buy on MediWound, Lowers Price Target to $6.5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MediWound (NASDAQ:MDWD) with a Buy and lowers the price target from $7 to $6.5.